Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-24 Sale | 2022-05-26 6:26 pm | GENOCEA BIOSCIENCES INC. | GNCA | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 10,376,936 | $0.07234 | $750,662 | 0 (Direct) | View |
| 2022-04-11 Purchase | 2022-04-13 5:00 pm | Trevi Therapeutics Inc. | TRVI | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 2,631,578 | $1.9 | $4,999,998 | 10,421,428 (Direct) | View |
| 2021-12-10 Sale | 2021-12-27 4:40 pm | Metacrine Inc. | MTCR | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 497,270 | $0.9944 | $494,483 | 2,563,257 (Direct) | View |
| 2021-10-18 Purchase | 2021-10-19 9:09 pm | Trevi Therapeutics Inc. | TRVI | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 1,851,852 | $0 | $0 | 11,493,554 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-18 5:08 pm | Marker Therapeutics Inc. | MRKR | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Direct) | View |
| 2020-12-04 Purchase | 2020-12-07 5:06 pm | Regulus Therapeutics Inc. | RGLS | Growth Equity Opportunities V LLC New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Direct) | View |
| 2020-09-18 Purchase | 2020-09-22 5:40 pm | Metacrine Inc. | MTCR | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 769,230 | $13 | $9,999,990 | 3,060,527 (Direct) | View |
| 2020-07-24 Purchase | 2020-07-28 5:19 pm | GENOCEA BIOSCIENCES INC. | GNCA | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 3,151,260 | $2.25 | $7,090,335 | 13,528,196 (Direct) | View |
| 2020-06-30 Purchase | 2020-07-01 5:45 pm | Akouos Inc. | AKUS | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 588,235 | $17 | $9,999,995 | 4,294,207 (Direct) | View |
| 2020-04-03 Sale | 2020-04-13 9:26 pm | Trevi Therapeutics Inc. | TRVI | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 564 | $2.66 | $1,500 | 5,937,998 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-13 Other | 2023-06-15 4:24 pm | N/A N/A | Mirum Pharmaceuticals Inc. | MIRM | NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 2,030,000 | $0 | 4,246,243 (Indirect) | View |
| 2022-11-30 Equity Swap | 2022-12-02 5:01 pm | N/A N/A | Akouos Inc. | AKUS | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 4,294,207 | $0 | 0 (Direct) | View |
| 2020-09-18 Conversion | 2020-09-22 5:40 pm | N/A N/A | Metacrine Inc. | MTCR | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 2,291,297 | $0 | 3,060,527 (Direct) | View |
Ownership | 2020-09-15 5:21 pm | N/A N/A | Metacrine Inc. | MTCR | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 0 | $0 | 2,291,297 (Direct) | View |
| 2020-06-30 Conversion | 2020-07-01 5:45 pm | N/A N/A | Akouos Inc. | AKUS | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 3,705,972 | $0 | 4,294,207 (Direct) | View |
Ownership | 2020-06-25 7:14 pm | N/A N/A | Akouos Inc. | AKUS | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 0 | $0 | 3,705,972 (Direct) | View |
| 2020-04-03 Exercise | 2020-04-13 9:26 pm | 2019-05-09 2022-05-06 | Trevi Therapeutics Inc. | TRVI | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 1,500,000 | $0 | 5,937,998 (Direct) | View |
| 2020-04-03 Exercise | 2020-04-13 9:26 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 1,500,000 | $0.001 | 5,937,998 (Direct) | View |
Ownership | 2020-01-29 8:08 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 0 | $0 | 2,648,757 (Direct) | View |